CDK4 - cyclin dependent kinase 4 Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 100144492
About CDK4
Primary_assembly 5: 23,038,891-23,042,061 reverse strand.Sscrofa11.1:CM000816.5
This gene has 1 transcript (splice variant), 214 orthologues and 27 paralogues. Ubiquitous expression in ovary (RPKM 76.), spleen (RPKM 48.6) and 8 other tissues.
CDK4 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001123097.1 | NP_001116569.1 | cyclin-dependent kinase 4 |
CDK4 Protein Structure
STKc_CDK4
STKc_CDK4: cd07863 (4 - 294)
- 0
- 100
- 200
- 303 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cyclin-dependent kinase 4 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(14)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-50767 | Palbociclib | Inhibitor | 99.94% | Unkown |
| HY-16297A | Abemaciclib | Inhibitor | 99.97% | Yes |
| HY-15777 | Ribociclib | Inhibitor | 99.94% | Unkown |
| HY-50767C | Palbociclib hydrochloride | Inhibitor | 99.96% | Unkown |
| HY-50767A | Palbociclib monohydrochloride | Inhibitor | 99.98% | Unkown |
| HY-A0065 | Palbociclib isethionate | Inhibitor | 99.98% | Unkown |
| HY-16297 | Abemaciclib methanesulfonate | Inhibitor | 99.95% | Yes |
| HY-15777B | Ribociclib succinate | Inhibitor | 99.93% | Unkown |
| HY-15777A | Ribociclib hydrochloride | Inhibitor | 99.95% | Unkown |
| HY-114338 | Dalpiciclib | Inhibitor | 99.70% | Unkown |
| HY-101467A | Trilaciclib hydrochloride | Inhibitor | 99.69% | Unkown |
| HY-15777C | Ribociclib succinate hydrate | Inhibitor | 99.94% | Unkown |
| HY-50767D | Palbociclib orotate | Inhibitor | / | Unkown |
| HY-50767B | Palbociclib dihydrochloride | Inhibitor | / | Unkown |
Clinical Phase
Bioactive Molecules
(32)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-10580 | GSK 3 Inhibitor IX | Inhibitor | 99.73% | Phase 4 |
| HY-114338A | Dalpiciclib hydrochloride | Inhibitor | 99.41% | Phase 4 |
| HY-122620 | Rafutrombopag (tautomerism) | Agonist | 98.33% | Phase 4 |
| HY-145589 | Rafutrombopag | Agonist | 95.29% | Phase 4 |
| HY-112272A | Lerociclib dihydrochloride | Inhibitor | 98.51% | Phase 3 |
| HY-112272 | Lerociclib | Inhibitor | 96.42% | Phase 3 |
| HY-175538 | USP10-IN-4 | Inhibitor | / | Phase 3 |
| HY-10005 | Flavopiridol | Inhibitor | 99.72% | Phase 2 |
| HY-101563 | GSK3326595 | 99.83% | Phase 2 | |
| HY-103712A | Samuraciclib hydrochloride | Inhibitor | 99.98% | Phase 2 |
| HY-50940 | AT7519 | Inhibitor | 99.69% | Phase 2 |
| HY-10006 | Flavopiridol Hydrochloride | Inhibitor | 99.73% | Phase 2 |
| HY-137478 | KB-0742 | Inhibitor | 99.63% | Phase 2 |
| HY-137478A | KB-0742 dihydrochloride | Inhibitor | 98.77% | Phase 2 |
| HY-10424 | Milciclib | Inhibitor | 99.89% | Phase 2 |
| HY-103712 | Samuraciclib | Inhibitor | 99.55% | Phase 2 |
| HY-103712B | Samuraciclib hydrochloride dihydrate | Inhibitor | 99.90% | Phase 2 |
| HY-50943 | AT7519 Hydrochloride | Inhibitor | 99.16% | Phase 2 |
| HY-103712C | Samuraciclib hydrochloride hydrate | Inhibitor | 99.88% | Phase 2 |
| HY-50940A | AT7519 TFA | Inhibitor | 99.75% | Phase 2 |
| HY-16559A | Riviciclib | Inhibitor | / | Phase 2 |
| HY-10008 | SNS-032 | Inhibitor | 99.91% | Phase 1 |
| HY-10012 | AZD-5438 | Inhibitor | 99.91% | Phase 1 |
| HY-10014 | R547 | Inhibitor | 99.57% | Phase 1 |
| HY-11001 | PHA-793887 | Inhibitor | 99.25% | Phase 1 |
| HY-15504 | RGB-286638 | Inhibitor | 99.67% | Phase 1 |
| HY-12624 | Narazaciclib | Inhibitor | 98.66% | Phase 1 |
| HY-12422 | Voruciclib | Inhibitor | 99.76% | Phase 1 |
| HY-111361 | FN-1501 | Inhibitor | 98.72% | Phase 1 |
| HY-15504A | RGB-286638 free base | Inhibitor | 98.09% | Phase 1 |
| HY-12422A | Voruciclib hydrochloride | Inhibitor | 99.26% | Phase 1 |
| HY-182468 | OP-3136 | 99.90% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(164)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-103248 | Toyocamycin | Inhibitor | 99.27% | Unkown |
| HY-15339 | CVT-313 | Inhibitor | 99.90% | Unkown |
| HY-10329 | JNJ-7706621 | Inhibitor | 99.39% | Unkown |
| HY-114177 | Ebvaciclib | Inhibitor | 99.98% | Unkown |
| HY-136250 | BSJ-03-204 | Inhibitor | 99.76% | Unkown |
| HY-116035 | Nimbolide | Inhibitor | 99.79% | Unkown |
| HY-122609 | XO44 | 99.38% | Unkown | |
| HY-138946 | XY028-140 | Inhibitor | 98.52% | Unkown |
| HY-18299A | Purvalanol A | Inhibitor | 98.61% | Unkown |
| HY-15275 | BMS-265246 | Inhibitor | 99.59% | Unkown |
| HY-N0404 | Sinigrin | Inhibitor | 99.97% | Unkown |
| HY-13914 | Roniciclib | Inhibitor | 98.00% | Unkown |
| HY-136252 | BSJ-04-132 | Inhibitor | 99.07% | Unkown |
| HY-18629 | SU9516 | Inhibitor | 99.85% | Unkown |
| HY-15878 | LDC000067 | Inhibitor | 99.00% | Unkown |
| HY-11009 | CGP60474 | Inhibitor | 98.90% | Unkown |
| HY-12445 | Asnuciclib | Inhibitor | 99.76% | Unkown |
| HY-N0805 | Alisol B 23-acetate | Inhibitor | 99.65% | Unkown |
| HY-128669 | Abemaciclib metabolite M2 | Inhibitor | 99.75% | Unkown |
| HY-15569 | NU6102 | Inhibitor | 99.23% | Unkown |
| HY-126534A | Abemaciclib metabolite M18 hydrochloride | Inhibitor | 98.18% | Unkown |
| HY-168664 | CPD-39 | Degrader | 98.06% | Unkown |
| HY-16559 | Riviciclib hydrochloride | 99.08% | Unkown | |
| HY-163786 | PROTAC CDK4/6 degrader 1 | Degrader | 98.88% | Unkown |
| HY-13266A | BS-181 hydrochloride | Inhibitor | 99.93% | Unkown |
| HY-119940 | MC180295 | Inhibitor | 98.07% | Unkown |
| HY-N1431 | Tabersonine | Inhibitor | 98.13% | Unkown |
| HY-147007 | β-catenin-IN-3 | Inhibitor | 95.64% | Unkown |
| HY-129336 | Abemaciclib metabolite M20 | Inhibitor | 95.92% | Unkown |
| HY-129180 | XY028-133 | Inhibitor | 99.07% | Unkown |
| HY-151071 | TMX-3013 | Inhibitor | 98.02% | Unkown |
| HY-100624 | Ryuvidine | Inhibitor | 99.23% | Unkown |
| HY-15889 | AMG 925 | Inhibitor | 99.02% | Unkown |
| HY-126534 | Abemaciclib metabolite M18 | Inhibitor | 98.01% | Unkown |
| HY-50767S | Palbociclib-d8 | Inhibitor | 99.84% | Unkown |
| HY-144995 | BSJ-02-162 | Inhibitor | 98.07% | Unkown |
| HY-163640 | CDK4 degrader 1 | Degrader | 99.83% | Unkown |
| HY-168660 | CPD-10 | Degrader | 98.59% | Unkown |
| HY-148214 | CDK2/4/6-IN-2 | Inhibitor | 98.20% | Unkown |
| HY-142076 | CDK4/6-IN-15 | Inhibitor | 99.32% | Unkown |
| HY-151069 | TMX-2039 | Inhibitor | 99.42% | Unkown |
| HY-150280 | Ironomycin | Inhibitor | 99.85% | Unkown |
| HY-148061 | DB1113 | 99.86% | Unkown | |
| HY-153894 | SRX3177 | Inhibitor | 99.33% | Unkown |
| HY-164129 | CDK4-IN-3 | Inhibitor | 98.07% | Unkown |
| HY-152263 | HEMTAC CDK4/6 degrader 1 | Inhibitor | 98.18% | Unkown |
| HY-N7045 | Isosilybin B | Inhibitor | 99.32% | Unkown |
| HY-107419 | NU6140 | Inhibitor | 99.53% | Unkown |
| HY-148062 | RSS0680 | 98.03% | Unkown | |
| HY-114339 | CDK4/6-IN-2 | Inhibitor | 99.67% | Unkown |
| HY-16942 | Damulin B | Inhibitor | ≥95.0% | Unkown |
| HY-123045 | PNU-292137 | Inhibitor | 99.95% | Unkown |
| HY-100429 | CAN508 | Inhibitor | 99.71% | Unkown |
| HY-126251 | CDK9-IN-7 | Inhibitor | 98.05% | Unkown |
| HY-119715 | AG-012986 | Inhibitor | 99.78% | Unkown |
| HY-129336S | Abemaciclib metabolite M20-d8 | Inhibitor | 99.26% | Unkown |
| HY-136726 | CGP-82996 | Inhibitor | 98.12% | Unkown |
| HY-155787 | SHR5428 | Inhibitor | 99.80% | Unkown |
| HY-112822 | ON-013100 | Inhibitor | 99.66% | Unkown |
| HY-45661 | Inixaciclib | Inhibitor | 99.93% | Unkown |
| HY-103380 | NSC 625987 | Inhibitor | 98.01% | Unkown |
| HY-142696A | CDK6/PIM1-IN-1 hydrochloride | Inhibitor | 99.38% | Unkown |
| HY-168996 | LA-CB1 | Degrader | 98.20% | Unkown |
| HY-146213 | CDK4/6-IN-12 | Inhibitor | 99.76% | Unkown |
| HY-115992 | CDK4/6-IN-9 | Inhibitor | 99.46% | Unkown |
| HY-112328 | Fascaplysin | Inhibitor | 95.64% | Unkown |
| HY-179688 | PROTAC CDK2/4 Degrader-1 | Degrader | / | Unkown |
| HY-201330 | GDC-4198 | Inhibitor | / | Unkown |
| HY-13266 | BS-181 | Inhibitor | 98.10% | Unkown |
| HY-148365 | NecroIr1 | Inhibitor | 98.53% | Unkown |
| HY-115909 | ZDLD20 | Inhibitor | 99.84% | Unkown |
| HY-168440 | Aurora-A ligand 1 | Ligand | 98.75% | Unkown |
| HY-148366 | NecroIr2 | Inhibitor | 98.02% | Unkown |
| HY-108420 | INK4C-IN-2 | Activator | 98.10% | Unkown |
| HY-123535 | P18IN003 | Activator | 99.49% | Unkown |
| HY-112243A | Cimpuciclib tosylate | Inhibitor | 99.65% | Unkown |
| HY-185121 | PROTAC CDK2/4/6 Degrader-2 | Degrader | 97.22% | Unkown |
| HY-142696 | CDK6/PIM1-IN-1 | Inhibitor | / | Unkown |
| HY-153556 | GW297361 | Inhibitor | 98.13% | Unkown |
| HY-112418 | CDK4/6-IN-18 | Inhibitor | 98.9% | Unkown |
| HY-N2423 | Sinigrin hydrate | Inhibitor | 99.92% | Unkown |
| HY-147125 | DDO-6600 | Inhibitor | 99.2% | Unkown |
| HY-112346 | RGB-286147 | Inhibitor | 98.60% | Unkown |
| HY-15889A | AMG 925 (HCl) | Inhibitor | / | Unkown |
| HY-164906 | TMX-2138 | Degrader | / | Unkown |
| HY-112450 | Olomoucine II | Inhibitor | 98.0% | Unkown |
| HY-111207 | CA224 | Inhibitor | 99.94% | Unkown |
| HY-112243 | Cimpuciclib | Inhibitor | / | Unkown |
| HY-126244 | CDK4/6-IN-3 | Inhibitor | / | Unkown |
| HY-159155 | CDK2/4-IN-1 | Inhibitor | / | Unkown |
| HY-151898 | CDK4/6-IN-14 | Inhibitor | / | Unkown |
| HY-179151 | CDK4/6-IN-26 | Inhibitor | / | Unkown |
| HY-181062 | VWK147 | Inhibitor | / | Unkown |
| HY-182044 | MRTX849-amide-C4-(o)-carborane | Inhibitor | / | Unkown |
| HY-141685 | 3-Methylthienyl-carbonyl-JNJ-7706621 | Inhibitor | / | Unkown |
| HY-176365 | Palbociclib-C4-Boc | Inhibitor | / | Unkown |
| HY-170651 | CDK4/6/HDAC-IN-1 | Inhibitor | / | Unkown |
| HY-171826 | PROTAC CDK2/4/6 Degrader-1 | Inhibitor | / | Unkown |
| HY-170992 | Autophagy agonist-1 | Inhibitor | / | Unkown |
| HY-163856 | CDK7-IN-30 | Inhibitor | / | Unkown |
| HY-172127 | NUAK1-IN-1 | Inhibitor | / | Unkown |
| HY-164376A | CDK4/6-IN-21 maleate | Inhibitor | / | Unkown |
| HY-164376 | CDK4/6-IN-21 | Inhibitor | / | Unkown |
| HY-181501 | CDK2/4/6-IN-3 | Inhibitor | / | Unkown |
| HY-172128 | NUAK1-IN-2 | Inhibitor | / | Unkown |
| HY-182986 | LS-Q2 | Inhibitor | / | Unkown |
| HY-147409 | Ulecaciclib | Inhibitor | / | Unkown |
| HY-185487 | CDK4/6-IN-27 | Inhibitor | / | Unkown |
| HY-115942 | Anticancer agent 29 | Inhibitor | / | Unkown |
| HY-155602 | CDK2-IN-18 | Inhibitor | / | Unkown |
| HY-168444 | CDK4/6-IN-23 | Inhibitor | / | Unkown |
| HY-137478B | KB-0742 hydrochloride | Inhibitor | / | Unkown |
| HY-183571 | JD128 | Inhibitor | / | Unkown |
| HY-172234 | PF-06842874 | Inhibitor | / | Unkown |
| HY-162529 | CDK4/6-IN-19 | Inhibitor | / | Unkown |
| HY-182447 | Contragestazol | Inhibitor | / | Unkown |
| HY-148213 | CDK2/4/6-IN-1 | Inhibitor | / | Unkown |
| HY-153336 | PRT3645 | Inhibitor | / | Unkown |
| HY-143257 | CDK4/6-IN-7 | Inhibitor | / | Unkown |
| HY-182752 | CDK1-IN-9 | Inhibitor | / | Unkown |
| HY-172198 | GSK3-IN-10 | Inhibitor | / | Unkown |
| HY-176718 | VEGFR-2-IN-69 | Inhibitor | / | Unkown |
| HY-W1047040 | CDK2/4 ligand 1 | Inhibitor | / | Unkown |
| HY-173237 | CDK4/6/BRD4-IN-1 | Inhibitor | / | Unkown |
| HY-178516 | PROTAC CDK4/6/9 degrader 2 | Degrader | / | Unkown |
| HY-153088 | CDK4/6-IN-16 | Inhibitor | / | Unkown |
| HY-111932 | Indirubin-5-sulfonate | Inhibitor | / | Unkown |
| HY-162619 | CDK9-IN-33 | Inhibitor | / | Unkown |
| HY-171656 | G721-0282 | Inhibitor | 99.96% | Unkown |
| HY-150609 | SHP2/CDK4-IN-1 | Inhibitor | / | Unkown |
| HY-115908 | ZDLD13 | Inhibitor | / | Unkown |
| HY-146276 | CDK/HDAC-IN-2 | Inhibitor | / | Unkown |
| HY-178452 | PROTAC CDK4/6/9 degrader 1 | Degrader | / | Unkown |
| HY-178168 | ARUK2010694 | Inhibitor | / | Unkown |
| HY-162530 | CDK4/6-IN-20 | Inhibitor | / | Unkown |
| HY-180912 | HS-36 | Inhibitor | / | Unkown |
| HY-114338B | Dalpiciclib isethionate | Inhibitor | / | Unkown |
| HY-134303 | CST651 | Degrader | / | Unkown |
| HY-115993 | CDK4/6-IN-10 | Inhibitor | / | Unkown |
| HY-178112 | CDK2-IN-47 | Inhibitor | / | Unkown |
| HY-115904 | FLT3/CDK4-IN-1 | Inhibitor | / | Unkown |
| HY-183297 | CDK4-IN-5 | Inhibitor | / | Unkown |
| HY-182734 | BMS-357075 | Inhibitor | / | Unkown |
| HY-128491 | UNC10112785 | Inhibitor | / | Unkown |
| HY-179375 | LCI133 | Inhibitor | / | Unkown |
| HY-143258 | CDK4/6-IN-8 | Inhibitor | / | Unkown |
| HY-183771 | CDK4/6-IN-28 | Inhibitor | / | Unkown |
| HY-160941 | CDK2-IN-29 | Inhibitor | / | Unkown |
| HY-123034 | CDKI-83 | Inhibitor | / | Unkown |
| HY-178171 | ARUK2010489 | Inhibitor | 96.64% | Unkown |
| HY-171740 | CDK4-IN-4 | Inhibitor | / | Unkown |
| HY-170815 | CDK4/9-IN-1 | Inhibitor | / | Unkown |
| HY-183854 | AG-12286 | Inhibitor | / | Unkown |
| HY-182470 | AG-012986 dihydrochloride | Inhibitor | / | Unkown |
| HY-123859 | SR-2890 | Inhibitor | / | Unkown |
| HY-171481 | Thio-acridone | Inhibitor | / | Unkown |
| HY-146253 | CDK1/2/4-IN-1 | Inhibitor | / | Unkown |
| HY-163787 | YY173 | Inhibitor | / | Unkown |
| HY-173172 | MG-002 | Inhibitor | / | Unkown |
| HY-118447 | RO0505124 | / | Unkown | |
| HY-11001A | PHA-793887 hydrochloride | Inhibitor | / | Unkown |
| HY-N1431A | Tabersonine hydrochloride | Inhibitor | 98.55% | Unkown |
| HY-183529 | Antitrypanosomal agent 31 | Inhibitor | / | Unkown |
| HY-102088 | P18IN011 | Inhibitor | / | Unkown |